Institutional shares held 46.8 Million
18.7K calls
61.9K puts
Total value of holdings $5.7B
$2.28M calls
$7.54M puts
Market Cap $5.62B
46,906,400 Shares Out.
Institutional ownership 99.76%
# of Institutions 478


Latest Institutional Activity in TFX

Top Purchases

Q1 2025
Ubs Group Ag Shares Held: 3.32M ($398M)
Q1 2025
Voloridge Investment Management, LLC Shares Held: 424K ($50.9M)
Q1 2025
D. E. Shaw & Co., Inc. Shares Held: 529K ($63.5M)
Q1 2025
Dimensional Fund Advisors LP Shares Held: 868K ($104M)
Q1 2025
Worldquant Millennium Advisors LLC Shares Held: 370K ($44.4M)

Top Sells

Q1 2025
Invesco Ltd. Shares Held: 134K ($16M)
Q1 2025
Janus Henderson Group PLC Shares Held: 4.33M ($519M)
Q1 2025
State Street Corp Shares Held: 1.53M ($183M)
Q1 2025
Alliancebernstein L.P. Shares Held: 45.9K ($5.5M)
Q1 2025
Vanguard Group Inc Shares Held: 5.08M ($610M)

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.


Insider Transactions at TFX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
85.4K Shares
From 20 Insiders
Grant, award, or other acquisition 37.2K shares
Exercise of conversion of derivative security 48.3K shares
Sell / Disposition
45.3K Shares
From 11 Insiders
Open market or private sale 2.67K shares
Payment of exercise price or tax liability 41.9K shares
Sale (or disposition) back to the issuer 655 shares

Track Institutional and Insider Activities on TFX

Follow TELEFLEX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFX shares.

Notify only if

Insider Trading

Get notified when an Teleflex Inc insider buys or sells TFX shares.

Notify only if

News

Receive news related to TELEFLEX INC

Track Activities on TFX